Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adecoagro SA (AGRO) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance

Adecoagro SA
Charles River Laboratories Intl. Inc

Price performance

Price movement over the last 24 hours

Key statistics

Adecoagro SA vs Charles River Laboratories Intl. Inc — how do they compare? Adecoagro SA trades at $10.12 (market cap $1.39B), while Charles River Laboratories Intl. Inc trades at $221.38 (market cap $11.01B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 7.9× Adecoagro SA's market cap, and Adecoagro SA pays a 3.08% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.

AGROCRL
Market Cap
$1.39B$11.01B
Sector
TechnologyHealth
52-Week High
$15.25$231.43
52-Week Low
$7.13$145.57
Enterprise Value
$3.42B$13.88B
Dividend Yield
3.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adecoagro SA

AGRO trades at $9.48, down 1.66% today, with a bearish technical signal despite neutral oscillators. The company reported mixed quarterly results, missing Q1 2026 EPS estimates but showing strong adjusted EBITDA growth. Valuation metrics appear attractive with P/S of 0.71 and P/B of 0.78, though profitability remains weak with a 0.91% net margin. Recent news highlights innovation in agriculture operations and a declared $0.12 dividend for H1 2026.

The stock offers value appeal with below-market multiples and analyst consensus target of $12.75 implying 34% upside. However, inconsistent earnings performance and negative net income in 2025 pose execution risks. The bearish technical trend and competitive pressures in sustainable agriculture require careful monitoring for potential investors.

Charles River Laboratories Intl. Inc

CRL trades at $228.68, down 0.87% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported negative net income of -$144.34M in 2025 despite revenue stability around $4.02B, resulting in a high P/E of 684.85. Recent earnings beats and strategic collaborations, such as with Lilly TuneLab (Business Wire, 2026-06-18), highlight operational strengths amid profitability challenges.

Outlook is mixed: strong analyst support (72% buy ratings) and positive cash flow trends contrast with negative margins and high debt. Key risks include sustained unprofitability and competitive pressures, but institutional confidence and technical momentum suggest potential for recovery if earnings improve.

Returns comparison

Trailing returns across standard periods

About Adecoagro SA

Adecoagro is a South American agricultural company. It operates a diversified business including farming crops, rice, and dairy, as well as producing sugar, ethanol, and renewable energy from its industrial facilities.

Read more on AGRO

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL